Earnings Positive

Spire Q2 2025 Earnings Preview

Breaking news from global financial markets

2 months ago
Read More
FATE THERAPEUTICS INC (NASDAQ:FATE) Reports Mixed Q2 2025 Results with Revenue Beat and Narrower Loss

FATE THERAPEUTICS INC (NASDAQ:FATE) Reports Mixed Q2 2025 Results with Revenue Beat and Narrower Loss

Earnings
2 months ago 2,496
Read More
Maze Therapeutics Inc (NASDAQ:MAZE) Reports Narrower Q2 2025 Loss, Extends Cash Runway to 2027

Maze Therapeutics Inc (NASDAQ:MAZE) Reports Narrower Q2 2025 Loss, Extends Cash Runway to 2027

Earnings
2 months ago 4,032
Read More
Cue Biopharma Inc (NASDAQ:CUE) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected

Cue Biopharma Inc (NASDAQ:CUE) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected

Earnings
2 months ago 1,954
Read More
Urgently Inc (NASDAQ:ULY) Q2 2025 Earnings: Revenue Meets Targets but EPS Falls Short

Urgently Inc (NASDAQ:ULY) Q2 2025 Earnings: Revenue Meets Targets but EPS Falls Short

Earnings
2 months ago 4,801
Read More
QuickLogic Corp (NASDAQ:QUIK) Misses Q2 2025 Revenue and EPS Estimates, Shares Drop Nearly 10%

QuickLogic Corp (NASDAQ:QUIK) Misses Q2 2025 Revenue and EPS Estimates, Shares Drop Nearly 10%

Earnings
2 months ago 2,682
Read More
SoundThinking Inc (NASDAQ:SSTI) Misses Q2 2025 Revenue and EPS Estimates, Reaffirms Full-Year Guidance

SoundThinking Inc (NASDAQ:SSTI) Misses Q2 2025 Revenue and EPS Estimates, Reaffirms Full-Year Guidance

Earnings
2 months ago 4,948
Read More
Prairie Operating Co. (NASDAQ:PROP) Q2 2025 Earnings Report: Revenue and EPS Fall Short, Market Shows Mixed Reaction

Prairie Operating Co. (NASDAQ:PROP) Q2 2025 Earnings Report: Revenue and EPS Fall Short, Market Shows Mixed Reaction

Earnings
2 months ago 3,378
Read More
SELLAS Life Sciences Group Inc (NASDAQ:SLS) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Amid Revenue Challenges

SELLAS Life Sciences Group Inc (NASDAQ:SLS) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Amid Revenue Challenges

Earnings
2 months ago 3,484
Read More
Pharvaris NV (NASDAQ:PHVS) Reports Wider Q2 2025 Loss, Highlights Clinical Trial Progress

Pharvaris NV (NASDAQ:PHVS) Reports Wider Q2 2025 Loss, Highlights Clinical Trial Progress

Earnings
2 months ago 1,294
Read More
iAnthus Reports Second Quarter 2025 Financial Results

iAnthus Reports Second Quarter 2025 Financial Results

Earnings
2 months ago 3,753
Read More
Brown & Brown, Inc. acquires the assets of Tire Shield

Brown & Brown, Inc. acquires the assets of Tire Shield

Earnings
2 months ago 3,638
Read More
Brown & Brown, Inc. acquires the assets of Tire Shield

Brown & Brown, Inc. acquires the assets of Tire Shield

Earnings
2 months ago 2,320
Read More
VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress

VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress

Earnings
2 months ago 2,065
Read More
ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss

ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss

Earnings
2 months ago 2,819
Read More
Rekor Systems Inc (NASDAQ:REKR) Q2 2025 Earnings: Revenue Misses, EPS Narrower Than Expected

Rekor Systems Inc (NASDAQ:REKR) Q2 2025 Earnings: Revenue Misses, EPS Narrower Than Expected

Earnings
2 months ago 3,007
Read More
Venture Global wins arbitration case against Shell over contracted LNG cargoes

Venture Global wins arbitration case against Shell over contracted LNG cargoes

Earnings
2 months ago 3,220
Read More
Venture Global wins arbitration case against Shell over contracted LNG cargoes

Venture Global wins arbitration case against Shell over contracted LNG cargoes

Earnings
2 months ago 2,182
Read More
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) Reports Q2 2025 Wider Loss but Extends Cash Runway with Strategic Restructuring

ORIC Pharmaceuticals Inc (NASDAQ:ORIC) Reports Q2 2025 Wider Loss but Extends Cash Runway with Strategic Restructuring

Earnings
2 months ago 574
Read More
OnKure Therapeutics Inc-A (NASDAQ:OKUR) Reports Q2 2025 Earnings Beat with Narrower-Than-Expected Loss

OnKure Therapeutics Inc-A (NASDAQ:OKUR) Reports Q2 2025 Earnings Beat with Narrower-Than-Expected Loss

Earnings
2 months ago 4,167
Read More

Trending Now

1

Nine-month interim report (Q3) 2025 (unaudited) - English version only

26,973 34 minutes ago
2

Nine-month interim report (Q3) 2025 (unaudited)

28,014 34 minutes ago
3

Kenya Construction Industry Report 2025: Output to Grow by 7.5% this Year - Resi...

20,184 34 minutes ago
4

Chevron's $55B Oil Grab Just Got Juicier--But There's a Wild AI Twist

49,600 34 minutes ago
5

Poland Embedded Finance Market Size & Forecast to 2030 by Value and Volume A...

9,255 36 minutes ago

Trending Topics

Sentiment (24h)

Positive
518
Neutral
139
Negative
114